Found 24 matching trials
Cladribine in Combination With GAP in Patients With Refractory/Relapsed Acute Lymphoblastic Leukemia
PHASE2The vast majority of patients with ALL will die of the disease, and no stan...
Location
Sun Yat-sen University Cancer Center
Cladribine in Combination With CAG in Patients With Refractory/Relapsed Acute Myeloid Leukemia
PHASE2The vast majority of patients with AML will die of the disease, and no stan...
Treatment of Hairy Cell Leukaemia Variant and Relapsing Hairy Cell Leukaemia With Cladribine Plus Rituximab
PHASE2The study will test the effectiveness (rate of complete remissions, total r...
Location
Community based hemato-oncology medical office
Efficacy and Safety of Cladribine in Combination With CAG in Newly Diagnosed Unfit Patients With AML
PHASE2In this study, the investigators conducted a phase II trial that evaluated ...
Location
Sun Yat-sen University Cancer Center
Cladribine Plus Homoharringtonine and Cytarabine Regimen (CHA) for de Novo Acute Myeloid Leukemia
PHASE2The goal of this clinical trial is to evaluate the response and safety of C...
Location
The First Affiliated Hospital, Zhejiang University School of Medicine
A Study of Cladribine, Low Dose Cytarabine, and Venetoclax in Treatment of Relapsed/Refractory or Secondary Acute Myeloid Leukemia
PHASE2Acute myeloid leukemia (AML) is a bone marrow cancer that is challenging to...
Location
Multiple Locations
A Study of Suboptimally Controlled Participants Previously Taking Injectable DMDs for RMS (CLICK-MS)
N/ATo evaluate the effectiveness, patient-reported outcomes (PROs) and safety ...
Location
University of Arkansas for Medical Sciences
Traditional Versus Early Aggressive Therapy for Multiple Sclerosis Trial
NAFDA-approved multiple sclerosis (MS) disease-modifying therapies (DMTs) tar...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Treatments Being Tested
Natalizumab/natalizumab-sztn, Alemtuzumab, Ocrelizumab, Rituximab/rituximab-arrx/rituximab-abbs/rituximab-pvvr, Cladribine, Ofatumumab, Ublituximab-xiiy, Ocrelizumab and hyaluronidase-ocsqGlatiramer acetate, Interferons (intramuscular, subcutaneous, pegylated) Teriflunomide, Fumarates (dimethyl, diroximel, monomethyl) Fingolimod, Siponimod, Ozanimod, Ponesimod Therapy Optimisation for the Treatment of Hairy Cell Leukemia
PHASE2The trial will test the effectiveness and toxicity of subcutaneous treatmen...
Location
Community based hemato-oncology medical office
Study of Chidamide Combined With Cladribine in Refractory/Relapsed Acute Myeloid Leukemia
PHASE2Acute myeloid leukemia (AML) is highly heterogeneous, the efficacy of the i...
Location
Department of Hematology, Zhongda Hospital Southeast University, Institute of Hematology Southeast University